Ripples Advisory Private Limited is one of the pioneers in the Indian financial tips industry to adopt best practices in research and delivery of its services to clients. Our company believes on the maximum customer support and prompt solution of all the queries regarding stock market. We are the SEBI registered advisory firm in India & provide you all investment recommendation in both segments.
USFDA inspects Baroda plant, no observations issued: Alembic
Alembic Pharmaceuticals today said no observations were issued by US health regulator USFDA after inspection of its Baroda facility. The bioequivalence facility was inspected by US Food & Drug Administration (USFDA) from March 6-10; March 13-17 and April 10-12, Alembic said in a filing to BSE. "There were no 483s issued by USFDA at the end of the inspection," it added.